QuickView for SCN5A;jsessionid=8D857E12124C79A8310A471B97D36743;jsessionid=7DADE0C15BD6CE0E50BEE0D86A9C301A;jsessionid=EC48EC531112A5E657560D8B4EA020F4 (gene)

Summary
General Info

Body Atlas

Most Correlated Tissues

Heart
Heart ventricle
Heart atrium
Vena cava
Skeletal muscle psoas

Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

Conduction disorder of the heart
Steinert myotonic dystrophy syndrome
Death
Muscle atrophy
COVID-19

Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

indecainide
Encainide
ethotoin
Flecainide
Mephenytoin

Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

TWIST1
AK096729
CHMP2B
ELF3
KHDRBS1

Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Explore Curated Studies Results

Literature

Most Relevant Literature

SCN5A channelopathy: arrhythmia, cardiomyopathy, epilepsy and beyond.
GPD1L-A306del modifies sodium current in a family carrying the dysfunctional SCN5A-G1661R mutation a…
The SCN5A Gene Is a Predictor of Phenotype Severity in Brugada Syndrome: A Comprehensive Literature …
Knockdown of SCN5A alters metabolic-associated genes and aggravates hypertrophy in the cardiomyoblas…
Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome.

Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for SCN5A;jsessionid=8D857E12124C79A8310A471B97D36743;jsessionid=7DADE0C15BD6CE0E50BEE0D86A9C301A;jsessionid=EC48EC531112A5E657560D8B4EA020F4

Explore Clinical Trials Results